Abstract
Lithium was associated with lower rates of suicide, self‐harm, and psychiatric hospital readmission among individuals with bipolar disorder, according to a cohort study that compared the effects of mood stabilizers and other treatments using both between‐ and within‐individual analyses. For all studied drugs, periods in treatment were associated with reduced psychiatric hospital admission compared with non‐treatment periods. Results were published online April 22, 2022, in the British Journal of Psychiatry.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
